These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19740488)

  • 21. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
    Wider C; Foroud T; Wszolek ZK
    Mov Disord; 2010; 25 Suppl 1():S15-20. PubMed ID: 20187245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic mutations in Parkinson disease.
    Tan EK; Skipper LM
    Hum Mutat; 2007 Jul; 28(7):641-53. PubMed ID: 17385668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging pathways in genetic Parkinson's disease.
    Lewis PA
    FEBS J; 2008 Dec; 275(23):5747. PubMed ID: 19021751
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetics of Parkinson's disease.
    Bonifati V
    Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].
    Takahashi R; Kawamata J; Takeuchi H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):885-7. PubMed ID: 20030238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic mechanisms of neurodegeneration in Parkinson disease.
    Mullin S; Schapira AH
    Neurol Clin; 2015 Feb; 33(1):1-17. PubMed ID: 25432720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.
    Funayama M; Hasegawa K; Ohta E; Kawashima N; Komiyama M; Kowa H; Tsuji S; Obata F
    Ann Neurol; 2005 Jun; 57(6):918-21. PubMed ID: 15880653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reassessment of the Lewy body.
    Au WL; Calne DB
    Acta Neurol Taiwan; 2005 Jun; 14(2):40-7. PubMed ID: 16008161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The progression of pathology in Parkinson's disease.
    Halliday GM; McCann H
    Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetics of Parkinson's syndromes: a critical review.
    Hardy J; Lewis P; Revesz T; Lees A; Paisan-Ruiz C
    Curr Opin Genet Dev; 2009 Jun; 19(3):254-65. PubMed ID: 19419854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.
    Hernandez D; Paisan Ruiz C; Crawley A; Malkani R; Werner J; Gwinn-Hardy K; Dickson D; Wavrant Devrieze F; Hardy J; Singleton A
    Neurosci Lett; 2005 Dec; 389(3):137-9. PubMed ID: 16102903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
    Krüger R
    BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].
    Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the genetics of dementia with lewy bodies.
    Bonifati V
    Curr Neurol Neurosci Rep; 2008 May; 8(3):187-9. PubMed ID: 18541113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.